Good morning, everyone, and nice to see you again. We hope the weekend respite was refreshing and relaxing, because that oh-so-familiar routine of meetings, deadlines, conference calls, and the like has, predictably, returned. But what can you do? The world, after all, keeps spinning. So to cope, we are firing up the coffee kettle to brew a few cups of stimulation. Our flavor today is caramel cream, for those tracking this sort of thing. Meanwhile, here are a few tidbits to get you started. Hope your journey goes well today and you conquer the world. …

Attorneys general from more than 40 states are alleging the nation’s largest generic drug makers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis, and other medical conditions, the Associated Press writes. The lawsuit, filed in federal court in Connecticut on Friday, also names 15 individual senior executives responsible for sales, marketing, and pricing along with 20 different companies. The suit was the second that has been filed in the price-fixing investigation. Here is the first one.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy